Safety, tolerability and metabolic effects of once weekly GL0034 (Utreglutide) in individuals with obesity: a multiple ascending dose study

被引：0
|
作者：
Thennati, R. [1 ]
Burade, V. [1 ]
Nagarajan, M. [1 ]
Shahi, P. [1 ]
Nagaraja, R. [1 ]
Agrawal, S. [1 ]
Duvauchelle, T. [2 ]
Garcia-Ocana, A. [3 ]
Rutter, G. [4 ,5 ]
Pratley, R. E. [6 ]
Thorens, B. [7 ]
Vilsboll, T. [8 ,9 ]
机构：
[1] Sun Pharmaceut Ind Ltd, Vadodara, India
[2] Phaster 1, Le Plessis Trevise, France
[3] Arthur Riggs Diabet & Metab Res Inst, Dept Mol & Cellular Endocrinol, Duarte, CA USA
[4] Imperial Coll London, Dept Metab, Digest, Reprod, London, England
[5] Univ Montreal, Crchum, Quebec City, PQ, Canada
[6] AdventHealth, Translat Res Inst Metab & Diabet, Orlando, FL USA
[7] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland
[8] Steno Diabet Ctr Copenhagen, Clin Res, Herlev, Denmark
[9] Univ Copenhagen, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
751
引用
收藏
页码：S359 / S360
页数：2
相关论文
共 50 条
  • [41] A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease
    Nygaard, Haakon B.
    Wagner, Allison F.
    Bowen, Garrett S.
    Good, Susan P.
    MacAvoy, Martha G.
    Strittmatter, Kurt A.
    Kaufman, Adam C.
    Rosenberg, Brian J.
    Sekine-Konno, Tomoko
    Varma, Pradeep
    Chen, Kewei
    Koleske, Anthony J.
    Reiman, Eric M.
    Strittmatter, Stephen M.
    van Dyck, Christopher H.
    ALZHEIMERS RESEARCH & THERAPY, 2015, 7
  • [42] Congenital muscular dystrophy ascending multiple dose cohort study analyzing pharmacokinetics at three dose levels in children and adolescents with assessment of safety and tolerability of omigapil (CALLISTO) trial update
    Leach, M.
    Foley, A.
    Averion, G.
    Hu, Y.
    Yun, P.
    DeCoster, J.
    Arevalo, C.
    Mendoza, C.
    Mayer, O.
    Hausmann, R.
    Cheung, K.
    Bonnemann, C.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S107 - S107
  • [43] Phase I Single Ascending Dose and Food Effect Study in Healthy Adults and Phase I/IIa Multiple Ascending Dose Study in Patients with Pulmonary Tuberculosis to Assess Pharmacokinetics, Bactericidal Activity, Tolerability, and Safety of OPC-167832
    Dawson, Rodney
    Diacon, Andreas H.
    Narunsky, Kim
    De Jager, Veronique R.
    Stinson, Kelly W.
    Zhang, Xiaoyan
    Liu, Yongge
    Hafkin, Jeffrey
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (06)
  • [44] Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study
    Mallikaarjun, Suresh
    Kane, John M.
    Bricmont, Patricia
    McQuade, Robert
    Carson, William
    Sanchez, Raymond
    Forbes, Robert A.
    Fleischhacker, W. Wolfgang
    SCHIZOPHRENIA RESEARCH, 2013, 150 (01) : 281 - 288
  • [45] Safety, tolerability, pharmacokinetics, & pharmacodynarnics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, in healthy male subjects: Multiple ascending dose study
    Kim, Dong-Kyu
    Lim, Kyoung Soo
    Cho, Joo-Youn
    Yu, Kyung-Sang
    Shin, Sang-Goo
    Kim, Sung-Ho
    Hwang, Dal-Mi
    Kwon, O. Hwan
    Lee, Sung-Hack
    Lee, Jaeick
    Kim, Jeong-Ae
    Jang, In-Jin
    Yim, Hyeon Joo
    DIABETES, 2008, 57 : A588 - A588
  • [46] Two-Part Phase 1 Multiple-Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of TRV734 in Healthy Adults
    Ramos, Kimberly A.
    James, Ian E.
    Skobieranda, Franck
    Soergel, David G.
    Ruff, Dennis
    Fossler, Michael J.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (01): : 51 - 62
  • [47] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Naloxegol at Peripheral and Central Nervous System Receptors in Healthy Male Subjects: A Single Ascending-Dose Study
    Eldon, Michael A.
    Kugler, Alan R.
    Medve, Robert A.
    Bui, Khanh
    Butler, Kathleen
    Sostek, Mark
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (06): : 434 - 441
  • [48] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF SINGLE- AND MULTIPLE-DOSE ONCE-DAILY BARICITINIB IN CHINESE HEALTHY VOLUNTEERS - A RANDOMIZED PLACEBO-CONTROLLED STUDY
    Zhao, Xia
    Payne, Christopher
    Wang, Feng
    Cui, Yiming
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 378 - 378
  • [49] Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study
    Zhao, Xia
    Sheng, Xiao Yan
    Payne, Christopher D.
    Zhang, Xin
    Wang, Feng
    Cui, Yi Min
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (08): : 952 - 960
  • [50] A randomized, double-blind, placebo-controlled, first-in-human single ascending dose, multiple ascending dose, and food effect study to evaluate the safety, tolerability, and pharmacokinetic profile of FM101 in healthy volunteers
    Ha, Seon-Ah
    Kim, Mi Ri
    Kang, Saehan
    Yu, Mira
    Park, Chong-Woo
    Lee, Jiyoun
    Kang, Jiyeon
    Kim, Ji-Young
    Seo, Seong Wook
    Son, Seohyun
    Cho, Hyeon Deok
    Lee, Hyuk Woo
    Jeong, Lak Shin
    JOURNAL OF HEPATOLOGY, 2020, 73 : S446 - S447
12345